By Denny Jacob

AMC Entertainment's proposed equity transactions were blocked after a judge rejected a proposed court settlement. Shares surged 74% in after-hours trading.

Medical technology company Becton Dickinson's updated BD Alaris Infusion System received 510(k) clearance from the Food and Drug Administration. Shares climbed 5.9% in aftermarket trading.

Verrica Pharmaceuticals' Ycanth topical solution for the treatment of molluscum contagiosum in adults and patients ages two and up was approved by the Food and Drug Administration. Shares slip 12% in after-hours trading.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

July 21, 2023 19:13 ET (23:13 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Verrica Parmaceuticals (NASDAQ:VRCA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Verrica Parmaceuticals Charts.
Verrica Parmaceuticals (NASDAQ:VRCA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Verrica Parmaceuticals Charts.